BioSpace News Archive

Teva Issues Recall of Tainted Blood Pressure Medicine, the Latest Global Recall for Valsartan

There has been another recall for blood pressure medications. This time Teva Pharmaceutical has issued a voluntary recall for combination forms of its blood pressure drug Amlodipine due to cancer-causing impurities discovered in the tablets.

November 28, 2018
·
2 min read
·
Alex Keown
Business

BC Platforms and University of Nottingham to create a Health Data Discovery Platform for the UK’s National Biobank Network

It is anticipated that this initial concept will be scaled to all UK biobanks and genomic cohorts and will be replicated across European countries wanting to adopt the UK model through working with European organisations such as BBMRI-ERIC and ELIXIR.

November 28, 2018
·
4 min read
Business

Anti-Vaccine Movement Causes First Deaths, Doctor Says

More than 200 children have died this year from influenza and 80 percent were not vaccinated, expert says.

November 28, 2018
·
2 min read
·
Alex Keown
Drug Development

Coeptis Pharma Buys Elto Pharma for Phase II Parkinson’s Asset

Elto Pharma is developing eltoprazine, which is in Phase IIb clinical development for Parkinson’s disease levodopa-induced dyskinesias, or Parkinson’s LID.

November 28, 2018
·
3 min read
·
Mark Terry
Drug Development

MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study (NOVA) to Evaluate Guselkumab in Hidradenitis Suppurativa

MorphoSys AG announced today that its licensee Janssen Research & Development, LLC (Janssen) initiated a phase 2 clinical study of guselkumab in patients with moderate to severe hidradenitis suppurativa (HS), a chronic skin disease also known as acne inversa.

November 28, 2018
·
6 min read
Business

EVOTEC AND IMMUNEERING TO COLLABORATE ON ARTIFICIAL INTELLIGENCE (‘AI’) DRIVEN LIGAND IDENTIFICATION FOR RARE HEREDITARY METABOLIC DISEASES

COMBINATION OF CUTTING-EDGE IPSC AND AI TECHNOLOGIES CREATES OPPORTUNITY TO DISCOVER NOVEL METABOLIC LIGANDS TO ACCELERATE DRUG DISCOVERY IN RARE METABOLIC DISEASES

November 28, 2018
·
4 min read
Policy

MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State

MDxHealth SA today announces that the New York State Department of Health has approved its SelectMDx test for Prostate Cancer.

November 28, 2018
·
4 min read
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as one of the commonly used maintenance medications in COPD (Chronic Obstructive Pulmonary Disease).

November 28, 2018
·
2 min read
Strong painkillers increase the risk of hip fracture among persons with Alzheimer’s disease

People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows.

November 28, 2018
·
1 min read
Eisai to Present Latest Data on Perampanel at 72nd American Epilepsy Society Annual Meeting

Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 72nd American Epilepsy Society Annual Meeting (AES 2018) to be held from November 30 to December 4, 2018 in New Orleans in the United States.

November 28, 2018
·
2 min read